Evidence map›Paper›PMID 21300148›Full record

ArticleFree radical biology & medicine2011

PARP inhibition alleviates diabetes-induced systemic oxidative stress and neural tissue 4-hydroxynonenal adduct accumulation: correlation with peripheral nerve function.

Sergey Lupachyk, Hanna Shevalye, Yury Maksimchyk, Viktor R Drel, Irina G Obrosova

Abstract read
In one paragraph

Article in Free radical biology & medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 82 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Diabetic neuropathy.Nature reviews. Disease primers · 2019
    Article
  17. Article
  18. Oxidative status of cardinal ligament in pelvic organ prolapse.Experimental and therapeutic medicine · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Sergey LupachykPennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA 70808, USA.
Hanna Shevalye
Yury Maksimchyk
Viktor R Drel
Irina G Obrosova
Louisiana State University System · USPennington Biomedical Research Center · US

Funding

Research BaseP30DK072476 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Sujoy Ghosh · 2005 to 2026
$26.5M
THE ROLE OF PROTEIN MALNUTRITION ON CIRCADIAN PHYSIOLOGY OF C57BL/6J MOUSE DAMSP20RR021945 · NCRR · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI GETTYS, THOMAS W · 2006 to 2011
$9.5M
Na+/H+-exchanger-1 and Diabetic NeuropathyR01DK077141 · NIDDK · UNIVERSITY OF IOWA · PI YOREK, MARK A. · 2008 to 2012
$1.6M
12/15-Lipoxygenase and Diabetic NeuropathyR01DK074517 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI OBROSOVA, IRINA G · 2007 to 2011
$1.5M
Peroxynitrite, protein nitration and advanced diabetic neuropathyR01DK081147 · NIDDK · UNIVERSITY OF IOWA · PI YOREK, MARK A. · 2010 to 2014
$1.4M
NCRR NIH HHS P20 RR021945NIDDK NIH HHS 1P30-DK072476NIDDK NIH HHS P30 DK072476NIDDK NIH HHS R01 DK074517NIDDK NIH HHS R01DK074517NIDDK NIH HHS R01 DK077141NIDDK NIH HHS R01DK077141NIDDK NIH HHS R01 DK081147NIDDK NIH HHS R01DK081147
6 · The paper itself

Abstract

This study evaluated the role of poly(ADP-ribose) polymerase (PARP) in systemic oxidative stress and 4-hydoxynonenal adduct accumulation in diabetic peripheral neuropathy. Control and streptozotocin-diabetic rats were maintained with or without treatment with the PARP inhibitor, 1,5-isoquinolinediol, 3 mg kg(-1) day(-1), for 10 weeks after an initial 2 weeks. Treatment efficacy was evaluated by poly(ADP-ribosyl)ated protein content in peripheral nerve and spinal cord (Western blot analysis) and dorsal root ganglion neurons and nonneuronal cells (fluorescence immunohistochemistry), as well as by indices of peripheral nerve function. Diabetic rats displayed increased urinary isoprostane and 8-hydroxy-2'-deoxyguanosine excretion (ELISA) and 4-hydroxynonenal adduct accumulation in endothelial and Schwann cells of the peripheral nerve, neurons, astrocytes, and oligodendrocytes of the spinal cord and neurons and glial cells of the dorsal root ganglia (double-label fluorescence immunohistochemistry), as well as motor and sensory nerve conduction velocity deficits, thermal hypoalgesia, and tactile allodynia. PARP inhibition counteracted diabetes-induced systemic oxidative stress and 4-hydroxynonenal adduct accumulation in peripheral nerve and spinal cord (Western blot analysis) and dorsal root ganglion neurons (perikarya, fluorescence immunohistochemistry), which correlated with improvement of large and small nerve fiber function. The findings reveal the important role of PARP activation in systemic oxidative stress and 4-hydroxynonenal adduct accumulation in diabetic peripheral neuropathy.

Indexed as

AldehydesAnimalsDiabetes Mellitus, ExperimentalIsoquinolinesMaleNerve TissueOxidative StressPeripheral NervesPoly(ADP-ribose) Polymerase InhibitorsPoly(ADP-ribose) PolymerasesQuinolinesRatsRats, Wistar1,5-dihydroxyisoquinoline4-hydroxy-2-nonenalAldehydesIsoquinolinesPoly(ADP-ribose) Polymerase InhibitorsPoly(ADP-ribose) PolymerasesQuinolines

Identifiers

PMID21300148
PMCPMC3081984
OpenAlexW2041609920

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.